Inhibitor of the glutamate vesicular transporter (VGLUT)
- PMID: 16101493
- DOI: 10.2174/0929867054637635
Inhibitor of the glutamate vesicular transporter (VGLUT)
Abstract
The vesicular glutamate transporter (VGLUT) is responsible for the uptake of the excitatory amino acid, L-glutamate, into synaptic vesicles. VGLUT activity is coupled to an electrochemical gradient driven by a vacuolar ATPase and stimulated by low Cl-. VGLUT has relatively low affinity (K(m) = 1-3 mM) for glutamate and is pharmacologically and structurally distinct from the Na+-dependent, excitatory amino acid transporters (EAATs) found on the plasma membrane. Because glutamatergic neurotransmission begins with vesicular release, compounds that block the uptake of glutamate into the vesicle may reduce excitotoxic events. Several classes of competitive VGLUT inhibitors have emerged including amino acids and amino acid analogs, fatty acids, azo dyes, quinolines and alkaloids. The potency with which these agents inhibit VGLUT varies from millimolar (amino acids) to nanomolar (azo dyes) concentrations. These inhibitors represent highly diverse structures and have collectively begun to reveal key pharmacophore elements that may elucidate the key interactions important to binding VGLUT. Using known inhibitor structures and preliminary molecular modeling, a VGLUT pharmacophore is presented that will aid in the design of new, highly potent and selective agents.
Similar articles
-
Design, synthesis and biological evaluation of small-azo-dyes as potent Vesicular Glutamate Transporters inhibitors.Eur J Med Chem. 2014 May 6;78:236-47. doi: 10.1016/j.ejmech.2014.03.056. Epub 2014 Mar 18. Eur J Med Chem. 2014. PMID: 24686010
-
Vesicular glutamate transporter-dependent glutamate release from astrocytes.J Neurosci. 2004 Mar 17;24(11):2633-42. doi: 10.1523/JNEUROSCI.3770-03.2004. J Neurosci. 2004. PMID: 15028755 Free PMC article.
-
Inhibition of the Vesicular Glutamate Transporter (VGLUT) with Congo Red Analogs: New Binding Insights.Neurochem Res. 2021 Mar;46(3):494-503. doi: 10.1007/s11064-020-03182-0. Epub 2021 Jan 4. Neurochem Res. 2021. PMID: 33398639 Free PMC article.
-
Molecular pharmacology of glutamate transporters, EAATs and VGLUTs.Brain Res Brain Res Rev. 2004 Jul;45(3):250-65. doi: 10.1016/j.brainresrev.2004.04.004. Brain Res Brain Res Rev. 2004. PMID: 15210307 Review.
-
Molecular physiology of vesicular glutamate transporters in the digestive system.World J Gastroenterol. 2005 Mar 28;11(12):1731-6. doi: 10.3748/wjg.v11.i12.1731. World J Gastroenterol. 2005. PMID: 15793854 Free PMC article. Review.
Cited by
-
Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders.Curr Pharm Des. 2009;15(14):1595-611. doi: 10.2174/138161209788168010. Curr Pharm Des. 2009. PMID: 19442176 Free PMC article. Review.
-
Docking and homology modeling explain inhibition of the human vesicular glutamate transporters.Protein Sci. 2007 Sep;16(9):1819-29. doi: 10.1110/ps.072944707. Epub 2007 Jul 27. Protein Sci. 2007. PMID: 17660252 Free PMC article.
-
A mini-review of the role of vesicular glutamate transporters in Parkinson's disease.Front Mol Neurosci. 2023 May 11;16:1118078. doi: 10.3389/fnmol.2023.1118078. eCollection 2023. Front Mol Neurosci. 2023. PMID: 37251642 Free PMC article. Review.
-
2-Year-Old and 3-Year-Old Italian ALS Patients with Novel ALS2 Mutations: Identification of Key Metabolites in Their Serum and Plasma.Metabolites. 2022 Feb 12;12(2):174. doi: 10.3390/metabo12020174. Metabolites. 2022. PMID: 35208248 Free PMC article.
-
Molecular, Structural, Functional, and Pharmacological Sites for Vesicular Glutamate Transporter Regulation.Mol Neurobiol. 2020 Jul;57(7):3118-3142. doi: 10.1007/s12035-020-01912-7. Epub 2020 May 30. Mol Neurobiol. 2020. PMID: 32474835 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources